Edwards Lifesciences Corp. Stock Underperforms Monday When Compared To Competitors

Dow Jones

2025.12.01 21:48

I'm PortAI, I can summarize articles.

Edwards Lifesciences Corp. (EW) shares fell 1.62% to $85.27 on Monday, marking the third consecutive day of losses. The stock underperformed compared to some competitors, with Abbott Laboratories (ABT) down 0.69%, Medtronic PLC (MDT) down 1.89%, and Stryker Corp. (SYK) up 0.31%. Trading volume was 2.6 million, below the 50-day average of 4.6 million. The stock is 2.44% below its 52-week high of $87.40.

This article was automatically generated by MarketWatch using technology from Automated Insights. Shares of Edwards Lifesciences Corp. (EW) slipped 1.62% to $85.27 Monday, on what proved to be an all-around dismal trading session for the stock market, with the S&P 500 Index falling 0.53% to 6,812.63 and Dow Jones Industrial Average falling 0.90% to 47,289.33. This was the stock's third consecutive day of losses. Edwards Lifesciences Corp. closed 2.44% short of its 52-week high of $87.40, which the company reached on November 26th. The stock demonstrated a mixed performance when compared to some of its competitors Monday, as Abbott Laboratories (ABT) fell 0.69% to $128.01, Medtronic PLC (MDT) fell 1.89% to $103.34, and Stryker Corp. (SYK) rose 0.31% to $372.32. Trading volume (2.6 M) remained 2.0 million below its 50-day average volume of 4.6 M. Data source: Dow Jones Market Data, FactSet. Data compiled December 1, 2025. This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal. (END) Dow Jones Newswires 12-01-25 1648ET